Abstract
The markers and triggers of sudden death in the general population have been well studied (1–3). In principle, they are related to the presence of a vulnerable myocardium in which some triggers or modulators may induce sudden death, generally through ventricular fibrillation (VF) (Fig. 1). Ventricular fibrillation may be triggered by a single event, as happens with a sustained ventricular tachycardia during a waterfall (Fig. 2) or by a more complex cascade of events (Fig. 3). Sometimes the final step is a bradyarrhythmia. This is relatively frequent in patients with advanced congestive heart failure (4) hut is rare in the ambulatory sudden death of patients with different types of heart disease (5) and in the acute phase of myocardial infarction (6) (Fig. 4).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Myerburg, R.J., Castellanos, A. Cardiac arrest and sudden cardiac death. In: Heart Disease. E. Braunwald (Ed.). WB Saunders Company: Philadelphia 1997, 742–79.
Bayés-Genis, A., Vinolas, X., Guindo, J., Fiol, M., Bayés de Luna, A. Electrocardiographic and clinical precursors of ventricular fibrillation: Chain of events. J Cardiovasc Electrophysiol 1995, 6: 410–7.
Goldstein, S., Bayés de Luna, A., Guindo Soldevila, J. Sudden Cardiac Death. Futura Publishing Company, Inc.: Armonk, New York 1994.
Luu, M., Stevenson, W.G., Stevenson, L.W., Baron, K., Walden, J. Diverse mechanism of unexpected cardiac arrest in advanced heart failures. Circulation 1988, 80: 1675–80.
Bayés de Luna, A., Coumel, P., Leclercq, J.F. Ambulatory sudden death: Mechanism of production of’fàtal arrhythmia syndromes on the bases of data from 157 cases. Am Heart J 1989, 117: 151–9.
Adgey, A.A., Devlin, J.E., Webb, S.W., Mulholland, H.C. Initiation of ventricular fibrillation outside hospital in patients with acute ischemic heart disease. Br Heart J 1982, 47: 55–6.
Thompson, P.D. The cardiovascular complications of vigorous physical activity. Arch Intern Med 1996, 156: 2297–302.
Kohl, H.W. III, Powell, K.E., Gordon, N.F., Blair, S.N., Paffenbarger, R.S. Physical activity, physical fitness and sudden cardiac death. Epidemiol Rev 1992, 14: 37–58.
Maron, B.J., Shirani, J., Poliac, L.C., Mathenge, R., Roberts, W.C., Mueeler, F.O. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 1996, 276 (3): 199–204.
Maron, B.J., Thompson, P.D., Puffer, J.C., et al. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young). American Heart Association. Circulation 1996, 94 (4): 850–6.
Consensus Statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States. Survivors of out-ofhospital cardiac arrest with apparently normal heart. Circulation 1997, 95: 265–72.
McKenna, W., Deanfield, J., Faruqui, A., England, D., Oakley, C.M., Goodwin, J.F. Prognosis in hypertrophic cardiomvopathy: Role of age and clinical and hemodvnamicfeatures. Am J Cardiol 1981, 47: 532–8.
Maron, B.J., Pelliccia, A., Spirito, P. Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete’s heart from structural heart disease, with particular emphasis on hypertrophie cardiomyopathy. Circulation 1995, 91: 1596–601.
Weber, K.T., Brilla, C.G. Pathological hypertrophy and cardiac interstitium. Fibrosis and reninangiotensin-aldosterone system. Circulation 1991, 83: 1849–65.
Pelliccia, A., Maron, B.J., Spataro, A., Proschan, M.A., Spirito, P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. New Engl J Med 1991, 324: 295–301.
Pons-Lladô, G., Carreras, F., Borrhs, X., Palmer, J., Llauger, J., Bayés de Luna, A. Comparison of morphological assessment of hypertrophic cardiomvopathy by magnetic resonance versus echocardiographlc imaging. Am J Cardiol 1997, 79: 1651–6.
Yasuda, T., Palacios, I.F., Dec, G.W., et al. Indium 111-monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis. Circulation 1987, 76: 306–11.
Obrador, D., Ballester, M., Carib, I., Bemà, L., Pons-Lladô, G. High prevalence of myocardial monoclonal antimyosin antibody uptake in patients with chronic dilated cardiomvopathy. J Am Coll Cadiol 1989, 13: 1289–93.
Khaw, B.A., Gold, H.K., Yasuda, T. Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody. Circulation 1986, 74: 501–8.
Ballester, M., Obrador, D., Carriô, I., et al. Early postoperative reduction of monoclonal antimyosin antibody uptake is associated with absent rejection-related complications after heart transplantation. Circulation 1992, 85: 61–8.
Vinolas, X., Carriô, I., Oter, R., et al. Evaluation of myocardial lesion after radiofrequency catheter ablation using In-111-antimyosin antibody prospective study. New Trends Arrhythmias 1995, 9: 745.
Subirana, M.T., Ferrés, P., Elosua, R., et al. 111-In-antimyosin antibody uptake in athletes with left ventricular hypertrophy. Eur Heart J 1997, 18: 252 (Abstract).
Rerych, S.K., Scholz, P.M., Sabiston, D.C., Jones, R.H. Effects of exercise training on left ventricular function in normal subjects: A longitudinal study by radionuclide angiography. Am J Cardiol 1980, 45: 244–52.
Fagard, R., Aubert, A., Lysens, R., Staessens, S., Vanhees, L., Amery, A. Non-invasive assessment of seasonal variations in cardiac structure and function in cyclists. Circulation 1983, 67: 896–901.
Fisman, E.Z., Frank, A.G., Ben-Ari, E., et al. Altered left volume and ejection fraction responses to supine dynamic exercise in athletes. J Am Coll Cardiol 1990, 15: 582–8.
Hess, O.M., Schneider, J., Koch, R., Bamert, C., Grimm, J., Krayenbuehl, H.P. Diastolic function and myocardial structure in patients with myocardial hypertrophy. Special reference to normalized viscoelastic data. Circulation 1981, 63: 360–71.
Skorton, D.J. Noninvasive assessment of myocardial composition and function in the hypertrophied heart. Circulation 1989, 80: 1095–7.
Lattanzi, F., Di Bello, V., Picano, E., et al. Normal ultrasonic myocardial reflectivity in athletes with increased left ventricular mass. A tissue characterization study. Circulation 1992, 85: 1828–34.
Diez, J., Laviades, C., Mayor, G., Gil, M.J., Monreal, I. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. Circulation 1995, 91: 1450–6.
Diez, J., Panizo, A., Gil, M.J., Monreal, I., Hernandez, M., Pardo-Mindân, J. Serum markers of collagen type 1 metabolism in spontaneuously hypertensive rats. Relation to myocardial fibrosis. Circulation 1996, 93: 1026–32.
Mehta, D., McKenna, W., Ward, D.E., Davies, M.J., Camm, A.J. Significance of signal-averaged electrocardiography in relation to endomyocardial biopsy and ventricular stimulation studies in patients with ventricular tachycardia without clinically apparent heart disease. J Am Coll Cardiol 1989, 14: 372–9.
Jordaens, L., Missault, L., Pelleman, G., Duprez, D., Backer, G.D., Clement, D.L. Comparison of athletes with life-threateing ventricular arrhythmias with two groups of healthy athletes and a group of normal control subjects. Am J Cardiol 1994, 74: 1124–8.
Kaski, J.C. Angina Pectoris with Normal Coronary Arteries. Sindrome X. Kluwer Academic Publishers: Boston 1995.
Iriate, M.M., Caso, R., Murga, N., Lopez de Argumedo, M., Sagastagoitia, D. Microvascular angina in systemic hypertension. - Diagnosis and treatment with enalapril. Am J Cardiol 1995, 76: 31–4.
Kleiger, R.E., Miller, J.P., Bigger, J.T., et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987, 59: 256–62.
Camm, J., Fei, L. Clinical significance of heart rate variability. In: Noninvasive Electrocardiology. Clinical Aspects of Holter monitoring. A.J. Moss, S. Stern (Eds.). W.B. Saunders Company Ltd.: London 1996, 225–48.
Marti, V., Guindo, J., Homs, E., Viflolas, X., Bayés de Luna, A. Peaks of QTc lengthening in Holter recording as a marker of life-threatening arrhythmias in postmyocardial infarction patients. Am Heart J 1992, 124: 234–5.
Homs, E., Marti, V., Guindo, J., et al. Automatic measurement of corrected QT interval in Hotter recordings: Comparison of its dynamic behavior in postmyocardial infarction patients with and without life threatening arrhythmias. Am Heart J 1997, 134 (Suppl. 2 Pt.l): 181–7.
Laguna, P., Thakor, N.V., Caminal, P., et al. New algorithm for QT interval analysis in 24-hour Molter ECG: Performance and applications. Med Biol Eng Comput 1990, 28: 67–73.
Vinolas, X., Bayés-Genis, A., Guindo, J., et al. Circadian repolarization patterns and ventricular arrhythmias. In: Noninvasive Electrocardiology. Clinical Aspects of Holter Monitoring. A.J. Moss, S. Stern (Eds.). W.B. Saunders Company Ltd.: London 1996, 479–91.
Zebrowski, J.J., Poplawska, W., Baranowski, R., Buchner, T. Local time properties of 24-hour hotter recordings RR intervals: A nonlinear quantitative method through patterns entropy of 3-D return maps. Computers in Cardiology 1995, 377–80.
Baranowski, R., Zebrowski, J.J., Poplawska, W., et al. 3-Dimensional poincare plots of the QT intervals -an approach to nonlinear QT analysis. Computers in Cardiology 1995, 789–92.
Wieland, D.W., Brown, L.E., Rogers, W.L., et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 1981, 22: 22–31.
Kline, R.C., Swanson, D.P., Wieland, D.M., et al. Myocardial imaging in man with 1–123 metaiodobenzylguanidine. J Nucl Med 1981, 22: 129–32.
Stanton, M.S., Tuli, M.M., Radtke, N.L., et al. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using 1–123-metaiodobenzvlguanidine. J Am Coll Cardiol 1989, 14: 1519–26.
Casses-Senon, D., Philippe, L., Cosnay, P., et al. Etude isotopique de la perfusion et de l’innervation myocardique chez 28 patients atteints de cardiomyopathie hypertrophique primitive: Relation avec les troubles du rythme ventriculaire. Arch Mal Coeur 1994, 87: 475–83.
Serra-Grima, J.S., Carrio, I., Estorch, M., et al. ECG alterations in the athlete type “pseudoischemia”. J Sports Card 1986, 3: 9–16.
Budoff, M.J., Georgiou, D., Brody, A., et al. Ultrafast computer tomography as a diagnostic modality in the detection of coronary artery disease: A multicenter study. Circulation 1996, 93 (5): 898–904.
Noble, J., Bourassa, M.G., Petitclerc, R., et al. Myocardial bridging and milking effect of the left anterior descending coronary artery: Normal variant or obstruction. Am J Cardiol 1976, 37: 993–9.
Nakamara, M., Takeshita, A., Nose, Y. Clinical characteristics associated with myocardial infarction, arrhythmias and sudden death in patients with vasospastic angina. Circulation 1987, 75: 1110–7.
Torner, P., Brugada, P., Smeets, J., et al. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. Eur Heart J 1991, 12: 144–50.
Della Bella, P., Brugada, R, Talajic, M., et al. Atrial fibrillation in patients with an accessory pathway: Importance of the conduction properties of the accessory pathway. J Am Coll Cardiol 1991, 17: 1352–6.
Moss, A.J., Schwartz, P.J., Crampton, R.S., et al. The long QT syndrome: Prospective longitudinal study of 328 families. Circulation 1991, 84: 1136–44.
Schwartz, P.J., Priori, S.G. Clinical utility of QT interval monitoring. In: Noninvasive Electrocardiology. Clinical Aspects of Holter Monitoring. A.J. Moss, S. Stern (Eds.). W.B. Saunders Company Ltd.: London 1996, 465–74.
Brugada, J., Brugada, R., Brugada, P. Right bundle-branch block and ST-segment elevation in leads VI through V3: A marker for sudden death in patients with demonstrable structural heart disease. Circulation 1998, 97 (5): 457–60.
Nademanee, K., Veerakul, G., Nimmannit, S., et al. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997. 96: 2595–600.
Corrado, D., Thiene, G., Nava, A., Rossi, L., Pennelli, N. Sudden death in young competitive athletes: Clinicopathologic correlations in 22 cases. Ans J Med 1990, 89: 588–96.
Corrado, D., Basso, C., Thiene, G., et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: A multicenter study. J Am Coll Cardiol 1997, 30 (6): 1512–20.
McKenna, W.J., Thiene, G., Nava, A., et al. Diagnosis of arrhythmogenic right ventricular dysplasio/cardiomyopathy. Task force of the working group myocardial and pericardial disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994, 71: 215–8.
Bayés de Luna, A. Clinical Electrocardiography. A Textbook. 2“d Updated Edition. Futura Publishing Company, Inc.: Armonk, New York 1998.
Day, C.P., McComb, J.M., Campbell, R.W.F. QT dispersion: An indication of arrhythmia risk in patients with long QT intervals. Br Heart J, 1990, 63: 342–4.
Biffi, A., Ansalone, G., Verdile, L. Ventricular arrhythmias and athlete’s heart. Role of signal-averaged electrocardiography. Eur Heart J 1996, 17: 557–63.
Marian A.J. Sudden cardiac death in patients with hypertrophic cardiomyopathy: From bench to bedside with an emphasis on genetic markers. Clin Cardiol 1995, 18: 189–98.
Vincent, G.M., Timothy, K.W., Leppert, M., Keating, M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT.syndrome. N Engl J Med 1992, 327: 846–52.
Rampazzo, A., Nava, A., Danieli, G.A., et al. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum Mol Genet 1994, 3: 959–62.
Marian, A.J., Roberts, R. Molecular genetic basis of hypertrophie cardiomyopathy: Genetic markers for sudden cardiac death. J Cardiovasc Electrophysiol 1998, 9: 88–99.
Muller, J.E., Tofler, G.H., Stone, P.H. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989, 79: 733–43.
Mittleman, M.A., Maclure, M., Tofler, G.H., Sherwood, J.B., Godberg, R.J., Muller, J.E. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. N Engl J Med 1993, 329: 1677–83.
Willich, S.N., Lewis, M., Löwel, H., Arntz, H.R., Shubert, F., Schroder, F. Physical exertion as a trigger of acute myocardial infarction. Triggers and mechanism of myocardial infarction group. N Engl J Med 1993, 329: 1684–90.
Siscovick, D.S., Weiss, N.S., Fletcher, R.H., Lasky, T. The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med 1984, 311: 874–7.
Lindinger, M.I. Potassium regulation during exercise and recovery in humans: Implications for skeletal and cardiac muscle. J Mol Cell Cardiol 1995, 27: 1011–22.
Stramba-Badiali, M., Guffanti, S., Porta, N., Frediani, M., Beria, G., Colnaghi, C. QT interval prolongation and cardiac arrest during antibiotic therapy with spiramycin in a newborn infant. Am Heart J 1993, 126: 740–2.
Woosley, R.L., Chen, Y., Freiman, J.P., Gillis, R.A. Mechanism of the cardiotoxic action of terfenadine. JAMA 1993, 269: 1532–6.
Wannamethee, G., Shaper, A.G. Alcohol and sudden cardiac death. Br Heart J 1992, 68: 443–8.
Nademanee, K. Cardiovascular effects and toxicities of cocaine. J Addict Dis 1992, 11: 71–82.
Maron, B.J., Poliac, LC., Kaplan, J.A., Mueller, F.O. Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. N Engl J Med 1995, 333 (6): 337–42.
Link, M.S., Wang, P.J., Pandian, N.G., et al. An experimental model of sudden death due to low-energy chest-wall impact (commode cordis). N Engl J Med 1998, 338: 1841–3.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Subirana, M.T. et al. (2000). Markers and Triggers of Sudden Death in Athletes. In: de Luna, A.B., Furlanello, F., Maron, B.J., Zipes, D.P. (eds) Arrhythmias and Sudden Death in Athletes. Developments in Cardiovascular Medicine, vol 232. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-0789-3_6
Download citation
DOI: https://doi.org/10.1007/978-94-017-0789-3_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-5470-8
Online ISBN: 978-94-017-0789-3
eBook Packages: Springer Book Archive